0001567619-20-004735.txt : 20200224 0001567619-20-004735.hdr.sgml : 20200224 20200224175247 ACCESSION NUMBER: 0001567619-20-004735 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200220 FILED AS OF DATE: 20200224 DATE AS OF CHANGE: 20200224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AYERS JONATHAN W CENTRAL INDEX KEY: 0001184149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 20645953 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2020-02-20 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001184149 AYERS JONATHAN W ONE IDEXX DRIVE WESTBROOK ME 04092 1 0 0 0 Common Stock 2020-02-20 4 M 0 23000 62 A 832861 D Common Stock 2020-02-20 4 S 0 4573 280.3420 D 828288 D Common Stock 2020-02-20 4 S 0 400 281.30 D 827888 D Common Stock 2020-02-20 4 S 0 1000 282.69 D 826888 D Common Stock 2020-02-20 4 S 0 1400 284.0440 D 825488 D Common Stock 2020-02-20 4 S 0 8375 285.9800 D 817113 D Common Stock 2020-02-20 4 S 0 4600 286.8140 D 812513 D Common Stock 2020-02-20 4 S 0 1424 287.7160 D 811089 D Common Stock 2020-02-20 4 S 0 300 288.6670 D 810789 D Common Stock 2020-02-20 4 S 0 928 290.2366 D 809861 D Common Stock 2020-02-21 5 G 0 650 0 D 809211 D Common Stock 2020-02-21 4 S 0 400 280.3988 D 137600 I by Ayers Family Trust Non-Qualified Stock Option (right-to-buy) 62 2020-02-20 4 M 0 23000 D 2024-02-13 Common Stock 23000 66070 D Represents the weighted average price of the shares sold ranging from a low of $280.04 to a high of $281.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $281.16 to a high of $281.72 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $282.30 to a high of $283.08 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $283.54 to a high of 284.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $285.51 to a high of $286.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $286.52 to a high of $287.51 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $287.54 to a high of $288.53 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $288.60 to a high of $288.71 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $290.07 to a high of $290.39 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Grant of option to buy 44,535 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2015 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers 2020-02-24